Ramsey J M, Schofield C J
Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Avenida Universidad 655, colonia Santa María Ahuacatitlán 625098, Cuernavaca, Morelos, México.
Salud Publica Mex. 2003 Mar-Apr;45(2):123-8. doi: 10.1590/s0036-36342003000200010.
Most Latin American countries are making dramatic progress in controlling Chagas disease, through a series of national and international initiatives focusing on elimination of domestic populations of Triatominae, improved screening of blood donors, and clinical support and treatment of persons infected with Trypanosoma cruzi. Some countries, particularly Uruguay, Chile and Brazil, are sufficiently advanced in their programmes to initiate detailed planning of the subsequent phases of Chagas disease control, while others such as Peru, Ecuador, and Mexico, are currently applying only the initial phases of the control campaigns. In this review, we seek to provide a brief history of the campaigns as a basis for discussion of future interventions. Our aim is to relate operational needs to the underlying biological aspects that have made Chagas disease so serious in Latin America but have also revealed the epidemiological vulnerability of this disease. The English version of this paper is available too at: http://www.insp.mx/salud/index.html.
大多数拉丁美洲国家通过一系列国家和国际举措,在控制恰加斯病方面取得了显著进展。这些举措聚焦于消灭家栖锥蝽种群、加强对献血者的筛查以及为感染克氏锥虫的人提供临床支持和治疗。一些国家,特别是乌拉圭、智利和巴西,其项目进展足够先进,已开始对恰加斯病控制的后续阶段进行详细规划,而其他国家,如秘鲁、厄瓜多尔和墨西哥,目前仅处于控制行动的初始阶段。在本综述中,我们试图简要介绍这些行动的历史,作为讨论未来干预措施的基础。我们的目的是将操作需求与使恰加斯病在拉丁美洲如此严重但也揭示了该疾病流行病学脆弱性的潜在生物学因素联系起来。本文的英文版本也可在以下网址获取:http://www.insp.mx/salud/index.html 。